Land: Nya Zeeland
Språk: engelska
Källa: Medsafe (Medicines Safety Authority)
Nandrolone decanoate 25 mg/mL
Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Nandrolone decanoate 25 mg/mL
25 mg/mL
Solution for injection
Active: Nandrolone decanoate 25 mg/mL Excipient: Arachis oil Benzyl alcohol
Syringe, Orgaject, disposible 1 mL, 1 mL
Prescription
Prescription
Aspen Oss B.V
DECA-DURABOLIN can be used for the treatment of osteoporosis; for the palliative treatment of selected cases of disseminated mammary carcinoma in women and as an adjunct to specific therapies and dietary measures in pathologic conditions characterized by a negative nitrogen balance.
Package - Contents - Shelf Life: Syringe, Orgaject, disposible 1 mL - 1 mL - 36 months from date of manufacture stored at or below 25°C
1969-12-31
NEW ZEALAND DATA SHEET Deca-Durabolin D130424 Version 3.1 Page1 DECA-DURABOLIN PRESENTATION Each pre-filled syringe contains 1 mL of 25 mg/ mL nandrolone decanoate. Each pre-filled syringe contains 1 mL of 50 mg/ mL nandrolone decanoate. Each pre-filled syringe is affixed with a needle CLOSED BY A NEEDLE SHIELD OF NATURAL RUBBER LATEX (See warnings and precautions for use). Each ampoule contains 1 ml of 50 mg/ml nandrolone decanoate. Each ml of the yellow, oily solution contains: 25 or 50 mg nandrolone decanoate. USES ACTIONS DECA-DURABOLIN is an injectable anabolic preparation. The pharmacologically active substance is nandrolone. The decanoate ester gives the preparation a duration of action of about three weeks after injection. Nandrolone is chemically related to the male hormone. Compared to testosterone, it has an enhanced anabolic and a reduced androgenic activity. This has been demonstrated in animal bioassays and explained by receptor binding studies. The low androgenicity of nandrolone is confirmed in clinical use. In the human, DECA-DURABOLIN has been shown to positively influence calcium metabolism and to increase bone mass in osteoporosis. In women with disseminated mammary carcinoma, DECA- DURABOLIN has been reported to produce objective regressions for many months. Furthermore, DECA-DURABOLIN has a nitrogen-saving action. This effect on protein metabolism has been established by metabolic studies and is utilized therapeutically in conditions where a protein deficiency exists such as during chronic debilitating diseases and after major surgery and severe trauma. In these conditions, DECA-DURABOLIN serves as a supportive adjunct to specific therapies and dietary measures as well as parenteral nutrition. Androgenic effects (e.g. virilisation) are relatively uncommon at Läs hela dokumentet